Report - RAJANI DEVI M(240450013466)

Plot No.2A, Street No.
1, Kakateeya Nagar, Habsiguda, Hyderabad, Telangana 500007
TEST REPORT
Name : Mrs. RAJANI DEVI M Registered on : 09-Jun-2024 10:29

Age/Gender : 37 Years / Female Collected on : 09-Jun-2024 10:31
Registration ID : 240450013466 Released on : 09-Jun-2024 16:26
Ref. By : Self Printed on : 09-Jun-2024 17:23
Sample Type : Serum Regn Centre : Boduppal - 45
LIPID PROFILE
TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

Serum Status : Clear
Triglycerides : 200 mg/dL Desirable level : < 150
Method: Glycerol Phosphate Oxidase (GPO), Borderline : 150 - 199
Peroxidase (POD) High : 200 - 499
Very High : > / = 500
Total Cholesterol : 283 mg/dL Desirable : < 200
Method: Cholesterol Oxidase Peroxidase (CHOD- Borderline high : 200 - 239
POD) High : > / = 240
LDL Cholesterol : 192 mg/dL Optimal : < 100
240450013466-Mrs. RAJANI DEVI M-37 Years-Female
Method: Calculated Near optimal : 100 - 129

Borderline high : 130 - 159
High : 160 - 189
Very high : > 190
HDL Cholesterol : 51 mg/dL Desirable level : > 60
Method: Enzymatic Immunoinhibition Optimal : 40 - 59
Undesriable : < 40
VLDL Cholesterol : 40 mg/dL < 30
Method: Calculation
Total Cholesterol / HDL Cholesterol : 5.5 Low risk : 3.3 - 4.4
Ratio Average risk : 4.5 - 7.1
Method: Calculation Moderate risk : 7.2 - 11.0
LDL Cholesterol / HDL Cholesterol Ratio : 3.8 Desirable level : 0.5 - 3.0
Method: Calculation Borderline risk : 3.0 - 6.0
High risk : > 6.0
Interpretation / Comments :
------------------------------------
• Lipid profile is a panel of blood tests that serves as an initial broad medical screening tool for abnormalities
in lipids, the results of this tests can identify certain genetic diseases and can determine approximate
risks for cardiovascular disease, certain forms of pancreatitis and other diseases.
DR. AYESHA TAHSEEN ANWARI

MC-6407
MD BIOCHEMISTRY
Registration No: TSMC/FMR/39915
Page 1 of 8
Plot No.2A, Street No. 1, Kakateeya Nagar, Habsiguda, Hyderabad, Telangana 500007
TEST REPORT

URIC ACID

Uric Acid : 3.4 mg/dL 2.6 - 6.0
Method: Uricase-Peroxidase
----------------------------------
• Useful for monitoring therapeutic management of gout and chemotherapeutic treatment of neoplasms.

MD BIOCHEMISTRY
MC-6407 Registration No: TSMC/FMR/39915
Page 2 of 8
TEST REPORT

UREA

Urea : 14 mg/dL 17 - 43
Method: Urease/GLDH
---------------------------------
• In conjunction with serum creatinine,urea level aids in differential diagnosis of pre-renal,renal and
post-renal hyperuremia.

MD BIOCHEMISTRY
Page 3 of 8
TEST REPORT

CREATININE

Creatinine : 0.7 mg/dL 0.5 - 1.0
Method: Jaffe Kinetic IDMS traceable
e-GFR (Glomerular Filtration Rate) : 114.0 ml/min/1.73 m² Normal kidney function : >/= 90
Method: Calculation, CKD EPI equation (Please refer to Interpretations for
reference ranges of e-GFR in
different stages of CKD and also
average e-GFR based on age. )
Interpretation / Comments:
Stages of chronic kidney disease (CKD)
Stages Description e-GFR

1 Possible kidney damage (eg: Proteinuria) with normal kidney function >/= 90
2 Mild loss of kidney function 60 - 89
3a Mild to moderate loss of kidney function 45 - 59
3b Moderate to severe loss of kidney function 30 - 44
4 Severe loss of kidney function 15 - 29
5 Kidney failure < 15
Chart for average e-GFR based on age

Age (Yrs) Average e-GFR
20 - 29 116
30 - 39 107
40 - 49 99
50 - 59 93
60 - 69 85
>/= 70 75
Page 4 of 8
TEST REPORT

CREATININE
• Serum Creatinine is useful in the diagnosis of renal insufficiency and is more specific and sensitive indicator of renal
disease than serum Urea /BUN.
• Use of simultaneous Urea / BUN and creatinine levels provide more information in the diagnosis of renal
insufficiency.
• GFR is generally considered the best index of overall kidney function.
• Chronic kidney disease is defined as the presence of persistent and usually progressive reduction in GFR.
• Repeated determination of GFR in conjunction with creatinine assay establish whether the patient has stable or
progressive disease.
• GFR is useful for people with chronic kidney disease (CKD) and those with risk factors for CKD (diabetes,
hypertension, cardiovascular disease and family history of kidney disease) to assess the kidney function.
• The CKD-EPI equation is the most widely used IDMS traceable equations for estimating GFR in patients above 18
years of age. This equation includes variables for age and gender, and it may be observed that Kidney may be involved
despite a serum creatinine concentration appearing to be within or just above the Biological Reference Interval. The
results of e-GFR by CKD-EPI equation are normalized to 1.73 m² body surface area. CKD-EPI equation is not valid
for individuals under 18 years of age.
• Limitations of CKD-EPI equation includes imprecise estimates in some individuals especially those suffering from
physiologic limitations of creatinine as filtration markers, thus showing large difference between measured GFR and
e-GFR (estimated GFR).
• Estimates for GFR based on serum creatinine will be less accurate for patients at the extremes of muscle mass (such as
frail elderly, critically ill, cancer patients) and also those with unusual diets, sudden acute renal failure, patients on
dialysis and patients with severe liver disease.
• Confirmatory tests with exogenous measured GFR or directly measured creatinine clearance should be performed for
such individuals.
• The influence of creatinine measurement imprecision at low creatinine conecentrations (and hence high e-GFR) has a
possible contribution to the variability at higher e-GFR values.

MC-6407
MD BIOCHEMISTRY
Page 5 of 8
TEST REPORT

ELECTROLYTES

Sodium : 138 mmol/L 136 - 146
Method: Indirect ISE
Potassium : 4.4 mmol/L 3.5 - 5.1
Chlorides : 100 mmol/L 101 - 109
------------------------------------
• Sodium : Levels of sodium when evaluated with electrolytes aid in assessing acid base balance, water balance and
water intoxication.
• Potassium : Useful in evaluation of electrolyte balance, cardiac arrhythmia, muscular weakness, hepatic
encephalopathy and renal failure.
• Chloride : Useful when assayed along with sodium, potassium and bicarbonate in assessment of electrolyte, acid base
and water balance.

MC-6407
MD BIOCHEMISTRY
Page 6 of 8
TEST REPORT

Sample Type : Whole Blood - EDTA Regn Centre : Boduppal - 45
GLYCATED HAEMOGLOBIN (HbA1C)

Glycated Haemoglobin : 8.1 % Non Diabetic : < 5.6
Pre - Diabetic Range : 5.7 - 6.4
Diabetic Range : >/= 6.5
Method: High performance liquid chromatography
Interpretation / Comments:
---------------------------------
• Glycated hemoglobin is proportional to mean plasma glucose level during previous 6-12 weeks.
• Values may not be comparable with different methodologies and even different laboratories using same methodology.
• Perform A1c at least twice annually in diabetes patients to ascertain meeting of goals.
• Perform A1c test quarterly in diabetes patients whose therapy has changed and who are not meeting goals.
• Recommended goal of A1c is < 7%.

• ADA guidelines 2023.
• Presence of abnormal Hb may affect HbA1C result.
Page 7 of 8
TEST REPORT

Sample Type : Whole Blood - EDTA Regn Centre : Boduppal - 45
GLYCATED HAEMOGLOBIN (HbA1C)


MD BIOCHEMISTRY
------------------ End of Report ------------------
Page 8 of 8

Report - RAJANI DEVI M(240450013466)

Uploaded by

Copyright:

Available Formats

You might also like

Report - RAJANI DEVI M(240450013466)

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Report - RAJANI DEVI M(240450013466)

Uploaded by

Copyright:

Available Formats

Plot No.2A, Street No.

1, Kakateeya Nagar, Habsiguda, Hyderabad, Telangana 500007

Name : Mrs. RAJANI DEVI M Registered on : 09-Jun-2024 10:29

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

Method: Calculated Near optimal : 100 - 129

DR. AYESHA TAHSEEN ANWARI

Name : Mrs. RAJANI DEVI M Registered on : 09-Jun-2024 10:29

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

DR. AYESHA TAHSEEN ANWARI

Name : Mrs. RAJANI DEVI M Registered on : 09-Jun-2024 10:29

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

DR. AYESHA TAHSEEN ANWARI

Name : Mrs. RAJANI DEVI M Registered on : 09-Jun-2024 10:29

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

Stages Description e-GFR

Chart for average e-GFR based on age

Name : Mrs. RAJANI DEVI M Registered on : 09-Jun-2024 10:29

DR. AYESHA TAHSEEN ANWARI

Name : Mrs. RAJANI DEVI M Registered on : 09-Jun-2024 10:29

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

DR. AYESHA TAHSEEN ANWARI

Name : Mrs. RAJANI DEVI M Registered on : 09-Jun-2024 10:29

GLYCATED HAEMOGLOBIN (HbA1C)

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

• Recommended goal of A1c is < 7%.

Name : Mrs. RAJANI DEVI M Registered on : 09-Jun-2024 10:29

GLYCATED HAEMOGLOBIN (HbA1C)

DR. AYESHA TAHSEEN ANWARI

------------------ End of Report ------------------

You might also like